Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
Date:8/8/2011

fiscal 2010.
  • Total operating expenses were $48.1 million in the first nine-months of fiscal 2011 compared to $20.3 million in the comparable period for fiscal 2010.
  • Cash used in operations was $42.5 million in the first nine-months of fiscal 2011.
  • Net loss for the first nine-months of fiscal 2011 was $42.6 million, or $0.36 per share, compared with a net loss of $17.0 million, or $0.20 per share for the comparable period in fiscal 2010.

  • NUEDEXTA RevenueFor the quarter ended June 30, 2011, the company reported NUEDEXTA gross and net revenue of $2.2 million and $1.9 million respectively. NUEDEXTA revenue is recognized using a deferred revenue recognition model, meaning that NUEDEXTA capsule shipments to wholesalers are initially recorded as deferred revenue and later recognized as revenue when the product has left the distribution channel and is no longer subject to a right of return, effectively representing reported end-user prescriptions and non-retail shipments of NUEDEXTA capsules.

    Business HighlightsRecent highlights for the company include:

  • In July, the company met with the European Medicines Agency (EMA) to discuss plans for filing a marketing authorization application (MAA) for NUEDEXTA for the treatment of pseudobulbar affect. Based on the outcome of the meeting, the company plans to request an accelerated review process and to file for approval of NUEDEXTA using the data package which served as the basis for the U.S. Food and Drug Administration approval of NUEDEXTA.  The timing of the company's MAA filing is subject to reaching an agreement with the EMA on a pediatric investigation plan for NUEDEXTA, which may occur before the end of calendar year 2011.
  • In April, the company filed an Investigational New Drug application with the U.S. Food and Drug Administration to begin a large Phase II clinical trial of AVP-923. The objectives of the PRIME study (Pain Research In Multiple sclErosis) a
    '/>"/>

  • SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
    2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
    4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
    5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
    7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
    8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
    9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
    10. Avanir Pharmaceuticals to Present at Three Conferences in March
    11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... , Sept. 2, 2014 Redspin, Inc., ... penetration testing services, today released an IT security advisory ... "Today,s healthcare CEOs are presiding over the most ... Daniel W. Berger , Redspin,s President and CEO. ... and their Boards of Directors understand why they need ...
    (Date:9/2/2014)... ATLANTA , Sept. 2, 2014  For over a ... show no link between vaccines and autism. But at least ... In a statement , William Thompson ... significant information" linking the MMR vaccine to an increased risk ... of the same data suggests that African American males ...
    (Date:9/2/2014)... Calif. , Sept. 2, 2014 /PRNewswire-iReach/ -- ... just recognized as one of the fastest growing ... past few years, the company has undergone significant ... research, late phase global clinical development, anti-viral and ... 2 years, WCCT Global has successfully participated in ...
    Breaking Medicine Technology:CDC vaccine scientist admits wrongdoing. 2CDC vaccine scientist admits wrongdoing. 3Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America 2
    ... SweetSpot Diabetes Care, Inc. has registered their ... Device Data System (MDDS) with the FDA the Company announced ... Sessions meeting in San Diego, CA. With the ... of data from patient diabetes devices to research tools and ...
    ... Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," ... that the Group has accumulated 754,791 ordinary shares in its ... the open market between December 2010 and March 2011. As ... the issued share capital of CCBC. CCBC is ...
    Cached Medicine Technology:Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5% 2
    (Date:9/2/2014)... At the world-famous Magic Castle in Hollywood, California, famed ... being the first and only female staff Medium. Throughout the ... female magician to hold such a position. , “I’m deeply ... says Misty Lee. “Even since I was a child, magic ... can fascinate guests in much the same way.” , At ...
    (Date:9/2/2014)... (PRWEB) September 02, 2014 QueenBeeTickets.com , ... events, is now stocking James Taylor concert tickets for the ... select U.S. cities from November 1 to the 19th. , ... and again on the 4th of the month. General onsales ... fans are all set to obtain seats for one of ...
    (Date:9/2/2014)... the U.S. has led to public debate about whether ... In January, President Obama also publically stated he is ... Despite the recent shift in views toward marijuana, the ... not well understood. , Now a new ... US High School Seniors: A Comparison of Alcohol and ...
    (Date:9/2/2014)... Smile Squared, a well-known Buy One, Give One ... US-made toothbrush. For every toothbrush purchased, Smile Squared gives ... was created by my wife and me after volunteering ... President of Smile Squared. “There, we saw children who ... of the same children didn't own a toothbrush. We ...
    (Date:9/2/2014)... Tuesday 2 September 2014: The fact that mechanical ... been confirmed by data from the ROPAC registry presented ... Hot Line session by Professor Jolien W. Roos-Hesselink, co-chair ... The registry found that 1.4% of pregnant women with ... baby during pregnancy. , The Registry Of Pregnancy And ...
    Breaking Medicine News(10 mins):Health News:Magician Misty Lee is the First and Only Female Staff Medium at Hollywood’s Magic Castle 2Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:NYU study compares consequences of teen alcohol and marijuana use 2Health News:NYU study compares consequences of teen alcohol and marijuana use 3Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3
    ... that treats Type-2 diabetes has been shown to prevent ... the growth of breast cancer cells, according to a ... The research, led by pediatrics professor James Trosko ... biological evidence for previously reported epidemiological surveys that long-term ...
    ... European Science Foundation (ESF) has awarded this year,s European ... Max Planck Institute for Demographic Research in Rostock, Germany. ... Vaupel was awarded the prize for his contributions to ... on demographic research. The Prize was awarded on the ...
    ... How will the terrorist attacks in Norway on 22 July ... social scientists at the University of Stavanger (UiS). "Norwegians ... Einar Olsen. "These incidents were so extensive and gruesome that ... He is very interested to see what content Norway will ...
    ... for cancer and epilepsy could also prevent heart attacks, according ... Gothenburg, Sweden, who have been using it to stimulate the ... are normally caused by the formation of a blood clot ... with oxygen and nutrients. The clot reduces the supply of ...
    ... News) -- Some patients with inflammatory bowel disease may ... their use of immunosuppressant drugs to treat the intestinal ... The studies, published in the November issue of ... commonly used to treat patients with irritable bowel disease, ...
    ... By Steven Reinberg HealthDay Reporter , TUESDAY, ... "energy" drinks skyrockets, so do related health problems, a ... almost 10 times more cases of reactions to beverages such ... to a new U.S. government report released Tuesday. More ...
    Cached Medicine News:Health News:Diabetes drug shows promise in reducing risk of cancer 2Health News:ESF awards 13th European Latsis Prize to James Vaupel on pioneering demographic research 2Health News:Coming to terms with terror 2Health News:Coming to terms with terror 3Health News:Coming to terms with terror 4Health News:Substance in cancer medicine could prevent heart attacks 2Health News:Chronic Bowel Disease Drugs Linked to Skin Cancer Risk 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 2Health News:ER Visits for Energy-Drink Ills Soar in U.S. 3
    ... Atlantech's new tibial guide is designed for ... to choose between "point" or "elbow" aimers ... for creation of the tibial tunnel. The ... design features and the reproducibility and accuracy ...
    The Pinn-ACL Guide can be used to create tibial tunnels of known lengths with a variable angle adjustment of 35 to 60 degrees with the use of a,graduated pin-sleeve....
    Hand surgery basic instrument set...
    Hand surgery basic instrument set with round handled instruments...
    Medicine Products: